Advanced Anaesthetic Management Strategies in Patients with Myoclonic Epilepsy with Ragged Red Fibers (MERRF)
DOI:
https://doi.org/10.55662/AJMRR.2024.5503Keywords:
Myoclonic Epilepsy with Ragged Red Fibers, MERRF, mitochondrial dysfunction, anaesthetic management, neuromuscular function, lactic acidosis, volatile anaesthetics, seizure control, personalized anaesthetic protocols, perioperative complicationsAbstract
Myoclonic Epilepsy with Ragged Red Fibers (MERRF) represents a complex and multifaceted mitochondrial disorder characterized by myoclonus, seizures, ataxia, and skeletal muscle involvement. The intricacies of anaesthetic management in this unique patient population necessitate a thorough understanding of the underlying pathophysiological mechanisms associated with mitochondrial dysfunction. As MERRF results from mutations in mitochondrial DNA, particularly within the mitochondrial genes associated with oxidative phosphorylation, it profoundly impacts neuromuscular function, thus necessitating tailored anaesthetic protocols. This paper aims to elucidate the anaesthetic challenges inherent in patients with MERRF, focusing on the implications of mitochondrial dysfunction on neuromuscular responses to anaesthetic agents and the subsequent perioperative management considerations.
In patients with MERRF, the propensity for lactic acidosis due to impaired mitochondrial energy metabolism complicates anaesthetic management. The accumulation of lactate during surgical interventions poses significant risks, particularly in the context of volatile anaesthetic agents, which can exacerbate mitochondrial dysfunction and precipitate neuromuscular weakness. The sensitivity to these agents necessitates meticulous dosing and monitoring to mitigate the risk of respiratory depression and other related complications. Furthermore, the role of neuromuscular blockade agents must be carefully considered, as the presence of underlying muscle weakness can lead to unpredictable neuromuscular responses and prolonged recovery times.
In addressing these anaesthetic challenges, this study offers a comprehensive framework for developing personalized anaesthetic protocols that prioritize patient safety and optimize surgical outcomes. Key components of this framework include the careful selection of anaesthetic agents, individualized titration based on the patient’s specific neuromuscular and mitochondrial status, and robust perioperative monitoring to swiftly identify and address potential complications. Emphasis is placed on the integration of multi-disciplinary approaches, wherein collaboration between anaesthesiologists, neurologists, and other healthcare providers is paramount to ensuring comprehensive perioperative care.
In addition to surgical management, this research underscores the importance of seizure control in the perioperative setting. MERRF patients are at an elevated risk for seizure activity due to inherent central nervous system involvement. Consequently, appropriate antiepileptic medications must be administered preoperatively, with careful consideration of potential drug interactions with anaesthetic agents. The aim is to maintain optimal seizure control while minimizing the risk of respiratory depression and hemodynamic instability during the perioperative period.
This study also addresses the importance of patient education and informed consent, emphasizing the need for clear communication regarding the anaesthetic risks associated with MERRF. Patients and their families must be well-informed about the unique challenges posed by the disorder, the potential for complications, and the strategies employed to mitigate these risks during surgical interventions. The inclusion of preoperative counselling as part of the anaesthetic management plan serves to empower patients and enhance their overall experience.
Downloads
References
Bottoni, P., Gionta, G., & Scatena, R. (2022). Remarks on mitochondrial myopathies. International Journal of Molecular Sciences, 24(1), 124–136. https://doi.org/10.3390/ijms24010124
Chou, S.-J., Tseng, W.-L., Chen, C.-T., Lai, Y.-F., Chien, C.-S., Chang, Y.-L., Lee, H.-C., Wei, Y.-H., & Chiou, S.-H. (2016). Impaired Ros scavenging system in human induced pluripotent stem cells generated from patients with MERRF syndrome. Scientific Reports, 6(1), 1–14. https://doi.org/10.1038/srep23661
Finsterer, J. (2021). Diagnosing myoclonic epilepsy with ragged-red fibres syndrome requires documentation of a causative mutation. A & A Practice, 15(9), 1-1. https://doi.org/10.1213/xaa.0000000000001525
Hsieh, V. C., Krane, E. J., & Morgan, P. G. (2017). Mitochondrial Disease and Anaesthesia. Journal of Inborn Errors of Metabolism & Screening, 5, 1–5. https://doi.org/10.1177/2326409817707770
Kumari, G., Chavan, M., Mehta, S. T., & Singh, A. (2023). Progressive Myoclonic Epilepsy: A Typical Case of MERRF and the Lessons Learnt. European Journal of Clinical Medicine, 4(3), 1–3. https://doi.org/10.24018/clinicmed.2023.4.3.261
Kynes, J. M., Blakely, M., Furman, K., Burnette, W. B., & Modes, K. B. (2018). Multidisciplinary perioperative care for children with Neuromuscular Disorders. Children, 5(9), 126–139. https://doi.org/10.3390/children5090126
Lopriore, P., Gomes, F., Montano, V., Siciliano, G., & Mancuso, M. (2022). Mitochondrial epilepsy, a challenge for neurologists. International Journal of Molecular Sciences, 23(21), 1–15. https://doi.org/10.3390/ijms232113216
Panditrao, M. M. (2016). Editorial: Anaesthesia and genetics: Still, the Uncharted Territories!! Journal of Anaesthesia & Critical Care: Open Access, 4(1). https://doi.org/10.15406/jaccoa.2016.04.00123
Valent, A., Pharaboz, A., Letord, A., Boughezala, S., Boccara, D., & Plaud, B. (2021). Perioperative management of an adult patient with myoclonic epilepsy with ragged red fibres syndrome: A case report. A & A Practice, 15(2), 1–4. https://doi.org/10.1213/xaa.0000000000001401
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
License Terms
Ownership and Licensing:
Authors of research papers submitted to the Asian Journal of Multidisciplinary Research & Review (AJMRR) retain the copyright of their work while granting the journal certain rights. Authors maintain ownership of the copyright and grant the journal a right of first publication. Simultaneously, authors agree to license their research papers under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) License.
License Permissions:
Under the CC BY-SA 4.0 License, others are permitted to share and adapt the work, even for commercial purposes, as long as proper attribution is given to the authors and acknowledgment is made of the initial publication in the Asian Journal of Multidisciplinary Research & Review. This license allows for the broad dissemination and utilization of research papers.
Additional Distribution Arrangements:
Authors are free to enter into separate contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., posting it to institutional repositories or publishing it in books), provided they acknowledge the initial publication of the work in the Asian Journal of Multidisciplinary Research & Review.
Online Posting:
Authors are encouraged to share their work online (e.g., in institutional repositories or on personal websites) both prior to and during the submission process to the journal. This practice can lead to productive exchanges and greater citation of published work.
Responsibility and Liability:
Authors are responsible for ensuring that their research papers do not infringe upon the copyright, privacy, or other rights of any third party. The Asian Journal of Multidisciplinary Research & Review disclaims any liability or responsibility for any copyright infringement or violation of third-party rights in the research papers.